Anabel De La Barrera Aira

Title: Anabel De La Barrera Aira: Innovator in Immunology

Introduction

Anabel De La Barrera Aira is a prominent inventor in the field of immunology, known for her groundbreaking work on enhancing the immunogenicity of poorly immunogenic antigens. Her innovative approach aims to develop pharmaceutical compositions that can generate effective immune responses, particularly in immunocompromised individuals.

Latest Patents

Anabel holds a patent titled "Pharmaceutical Compositions Enhancing The Immunogenicity Of Poorly Immunogenic Antigens." This invention focuses on immunogenic compositions that include peptides, polypeptides, proteins, their corresponding DNA sequences, cells or their lysates, and very small size proteoliposomes (VSSP). The patent outlines methods for preparing immunostimulating compositions capable of generating antigen-specific immune responses, even in patients suffering from conditions such as cancer and chronic infections.

Career Highlights

Anabel is associated with the Centro De Inmunologia Molecular, where she contributes her expertise to the advancement of immunological research. Her work is pivotal in developing vaccine compositions that can protect against or treat infectious, malignant, and autoimmune diseases.

Collaborations

Anabel collaborates with notable colleagues, including Luis Enrique Fernandez Molina and Belinda Sanchez Ramirez, who share her commitment to advancing immunological science.

Conclusion

Anabel De La Barrera Aira's contributions to immunology through her innovative patent work and collaborations highlight her dedication to improving health outcomes for vulnerable populations. Her research continues to pave the way for new therapeutic strategies in the fight against various diseases.